首页> 外文期刊>Journal of Heterocyclic Chemistry: The International Journal of Heterocyclic Chemistry >Polycyclic N-heterocyclic compounds. Part 66: Synthesis of N-[2-([1,2,4]oxadiazol-5-yl)cyclopenten-1-yl]formamide oximes and their evaluation as inhibitors of platelet aggregation
【24h】

Polycyclic N-heterocyclic compounds. Part 66: Synthesis of N-[2-([1,2,4]oxadiazol-5-yl)cyclopenten-1-yl]formamide oximes and their evaluation as inhibitors of platelet aggregation

机译:多环N-杂环化合物。第66部分:N- [2-([1,2,4]恶二唑-5-基)环戊烯-1-基]甲酰胺肟的合成及其作为血小板聚集抑制剂的评估

获取原文
获取原文并翻译 | 示例
           

摘要

N-[2-([1,2,4]Oxadiazol-5-yl)cyclopenten-1-yl]formamide oximes were synthesized by fusion of (6,7-dihydro-5H-cyclopenta[1,2-d]pyrimidin-4-yl) amidines and/or their amide oximes with hydroxylamine hydrochloride through a subsequent rearrangement reaction. Assay of the products for anti-platelet aggregation activity revealed that certain of them showed promising inhibitory effect on arachidonic acid-induced platelet aggregation.
机译:N- [2-([[1,2,4] Oxadiazol-5-yl)cyclopenten-1-yl]甲酰胺肟是通过(6,7-dihydro-5H-cyclopenta [1,2-d] pyrimidin的融合而合成的通过随后的重排反应,将4-(-4-基)am和/或它们的酰胺肟与羟胺盐酸盐反应。对产物的抗血小板聚集活性的测定表明,它们中的某些对花生四烯酸诱导的血小板聚集显示出有希望的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号